K. Gao, L. Ma, X. Wang, L. Zuou, X.F. Wang, Application of drug nanocrystal technologies on Oral drug delivery of poorly soluble drugs, Pharm. Res. 30 (2013) 307-324.
 J.B. Dressman, C. Reppas, In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs, Eur. J. Pharm. Sci. 11 Suppl. 2 (2000) S73-S80.
 M. Wang, M. Thanou, Targeting nanoparticles to cancer, Pharmacol. Res. 62 (2010) 90-99.
 A.T.M. Serajuddin, Solid dispersion of poorly-soluble drugs: early promises, subsequent problems, and recent breakthroughs, J. Pharm. Sci. 88 (1999) 1058-1066.
 M.E. Davis, M.E. Brewster, Cyclodextrin-based pharmaceutics: past, present and future, Nat. Rev. Drug Discov. 12 (2004) 1023-1035.
 J. Breitenbach, Melt extrusion: from process to drug delivery technology, Eur. J. Pharm. Biopharm. 54 (2002) 107-117.
 S.S. Davis, C. Washington, P. West, L. Illum, G. Liversidge, L. Sternson, R. Kirsh, Lipid emulsions as drug delivery systems, Ann. N. Y. Acad. Sci. 507 (1987) 75-88.
 K. Kawakami, T. Yoshikawa, T. Hayashi, Y. Nishihara, K. Masuda, Microemulsion formulation for enhanced absorption of poorly soluble drugs II in-vivo study, J. Control Release, 81 (2002) 75-82.
 D.B. Fenske, A.Chonn, P.R. Cullis, Liposomal nanomedicines: an emerging field, Toxicol. Pathol. 36 (2008) 21-29.
 V.P. Torchilin, Multifunctional nanocarriers, Adv. Drug Deliver. Rev. 64 (2012) 302-315.
 R.J. Aitken, M.Q. Chaudhry, A.B.A. Boxall, M. Hull, Manufacture and use of nanomaterials: current status in the UK and global trends, Occup. Med. 56 (2006) 300-306.
 K. Praveen, C. Singh, A study on solubility enhancement methods for poorly water-soluble drugs, Am. J. Pharmacol. Sci. 14 (2013) 67-73.
 S.K. Poornachary, G. Han, J.W. Kwek, P.S. Chow, R.B.H. Tan, Crystallizing micronized particles of a poorly water-soluble active pharmaceutical ingredient: nucleation enhancement by polymeric additives, Cryst. Growth Des. 16 (2016) 749-758.
 A.R. Mokarram, A. Kebriaeezadeh, M. Keshavarz, A. Ahmadi, B. Mohabat, Preparation and in-vitro evaluation of indomethacin nanoparticles, DARU J. of Pharm. Sci. 18 (2010) 185-192.
 H.P. Thakkar, B.V. Patel, S.P. Thakkar, Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement, J. Pharm. Bioallied Sci. 3 (2011) 426-434.
 J.P.J. Dhaval, M.P. Vikram, R.J. Rishad, R. Patel, Optimization of formulation parameters on famotidine nanosuspension using factorial design and the desirability function, Int. J. PharmTech Res. 2 (2010) 155-161.
 P.R.J. Khadka, H. Kim, I. Kim, J.Y. Kim, H. Kim, J.M. Cho, G. Yun, J. Lee, Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution, and bioavailability, Asian J. Pharma. Sci. 9 (2014) 304-316.
 J. Leleux, R.O. Williams, Recent advancements in mechanical reduction methods: particulate system, Drug Dev. Ind. Pharm. 3109 (2013) 1-12.
 N. Rasenack, B. W. Muller, Micron-size drug particles: common and novel micronization techniques, Pharm. Dev. Technol. 9 (2004) 1-13.
 T. Yajima, S. Itai, H. Hayashi. K. Takayama, T. Nagai, Optimization of size distribution of granules for tablet compression, Chem. Pharm. Bull. 44 (1996) 1056-1060.
 B.Y. Shekunov, P. Chattopadhyay, H.H.Y. Tang, A.H.L. Chow, Particle size analysis in pharmaceutics: principles, methods and applications, Pharm. Res. 24 (2007) 203-227.
 C.A. Maryanoff, L. Scott, K.L. Sorgi, U.S. Patent No. 5,387,700 (issued Feb 7, 1995).
 a) Food and Drug Administration, Center for Drug Evaluation and Research, Application Number 020505s038s039, 020844s032s034lbl. b) Ӧrn ALMARSSON, M.L. Peterson, J. Remenar, EP 1,485,388A2 (Issued Dec. 15, 2004).
 B.E. Maryanoff, S.O. Nortey, J.F. Gardocki, R.P. Shank, S.P. Dodgson, Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-beta -D-fructopyranose sulfamate and related compounds, J. Med. Chem. 30 (1987) 880-887.
 A. Ferrari, I. Tiraferri, L. Neri, E. Sternieri, Clinical pharmacology of topiramate in migraine prevention, Expert Opin. Drug Met. 7 (2011) 1169-1181.
 Food and Drug Administration, Center for Drug Evaluation and Research, Application Number 22580Orig1s000.
 B.A. Johnson, N. Ati-Daoud, Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients, Curr. Pharm. Design, 16 (2010) 2103-2112.
 L.H. Wang, C.T. Huang, U.S. Patent No. 8,748,594 (issued Jun. 10, 2014).
 D.P. Balwant, L.P. Kumar, P.A. Kumar, H.B. Prafulbhai, WO/2007/108009 (issued Sep. 9, 2007).
 H.P. Chawla, A.S. Chowdhary, S.M. Patel, WO/2007/099388 (issued Sep. 07, 2007).